title: Provider practice models for and costs of delivering medication abortion -- evidence from 11 US abortion care settings.
abstract: OBJECTIVE
  Understanding practice models and provider costs for medication abortion (MAB) provision may elucidate ways to facilitate MAB integration into a larger arena of health care services. This study provides descriptive data on the diverse MAB practice models currently being utilized by US health care providers and the costs associated with the components of those models.
  
  
  METHODS
  Data were gathered from a sample of 11 abortion care settings, using clinic administrative records and patient satisfaction surveys.
  
  
  RESULTS
  Practice models varied dramatically, with a wide range in the type of staff employed to provide MAB. The total episode cost for providing MAB ranged from 252 to 460 US Dollars, and patient satisfaction was high across all practices.
  
  
  CONCLUSIONS
  Information from this study can be used to guide decisions regarding MAB integration into practices not currently providing abortion or which provide only aspiration abortions. The information may also be useful for providers wishing to refine their MAB services.
authors.affiliation: University of California, San Francisco and Advancing New Standards in Reproductive Health (ANSIRH) program, Bixby Center for Reproductive Health Research & Policy, San Francisco, CA 94143, USA. aafable-munsuz@ucsf.edu
authors.forename: Aimee
authors.initials: A
authors.lastname: Afable-Munsuz
authors.forename: Heather
authors.initials: H
authors.lastname: Gould
authors.forename: Felicia
authors.initials: F
authors.lastname: Stewart
authors.forename: Kathryn A
authors.initials: KA
authors.lastname: Phillips
authors.forename: Stephanie L
authors.initials: SL
authors.lastname: Van Bebber
authors.forename: Charlie
authors.initials: C
authors.lastname: Moore
mesh_terms: D000021:Abortifacient Agents, Steroidal / Q000191:economics / Q000494:pharmacology*; D000028:Abortion, Induced / Q000191:economics* / Q000379:methods*; D000293:Adolescent; D000328:Adult; D003365:Costs and Cost Analysis; D003625:Data Collection; D005260:Female; D005102:Health Expenditures; D006268:Health Facilities / Q000191:economics* / Q000706:statistics & numerical data; D006801:Humans; D015735:Mifepristone / Q000191:economics / Q000494:pharmacology*; D017060:Patient Satisfaction; D010818:Practice Patterns, Physicians'; D011247:Pregnancy; D014481:United States
chemical_list: D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone